Daniel Passeri | executive |
Anish Suri | executive |
Matteo Levisetti | executive |
Kerri-Ann Millar | executive |
Maurice Raycroft | analyst |
Stephen Willey | analyst |
Reni Benjamin | analyst |
Greetings and welcome to the Cue Biopharma Investor Update Call. [Operator Instructions].
As a reminder, this conference is being recorded. I would now like to turn the conference over to Dan Passeri, Cue Biopharma's Chief Executive Officer.
You may begin now.